Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor

Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor

Cancer immunotherapy including adoptive T cell therapy (ACT) is widely used in the clinic and is highly beneficial for patients with hematological malignancies; however, it remains a challenge to develop effective immunotherapy strategies for the treatment of solid cancers, due to the inefficiency o...

Full description

Bibliographic Details
Main Authors: Qingzhi Jiang, Chi Zhang, Huilan Wang, Tao Peng, Li Zhang, Yang Wang, Weidong Han, Chunmeng Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Oncology
Subjects:
tumor targeting
mitochondria
immunogenic cell death
adoptive T-cell therapy
immunotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01196/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01196/full

Similar Items